Cargando…

Toxoplasma gondii Infection in the United States, 1999–2000

Infection with Toxoplasma gondii can lead to congenital and acquired disease, resulting in loss of vision and neurologic illness. We tested sera collected in the National Health and Examination Survey (NHANES) from 1999–2000 for T. gondii–specific immunoglobulin G antibodies and compared these resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Jeffrey L., Kruszon-Moran, Deanna, Wilson, Marianna
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035540/
https://www.ncbi.nlm.nih.gov/pubmed/14718078
http://dx.doi.org/10.3201/eid0911.030098
_version_ 1782197780298596352
author Jones, Jeffrey L.
Kruszon-Moran, Deanna
Wilson, Marianna
author_facet Jones, Jeffrey L.
Kruszon-Moran, Deanna
Wilson, Marianna
author_sort Jones, Jeffrey L.
collection PubMed
description Infection with Toxoplasma gondii can lead to congenital and acquired disease, resulting in loss of vision and neurologic illness. We tested sera collected in the National Health and Examination Survey (NHANES) from 1999–2000 for T. gondii–specific immunoglobulin G antibodies and compared these results with results from sera obtained in the NHANES III survey (1988–1994). NHANES collects data on a nationally representative sample of the U.S. civilian population. Of 4,234 persons 12–49 years of age in NHANES 1999–2000, 15.8% (age-adjusted, 95% confidence limits [CL] 13.5, 18.1) were antibody positive; among women (n=2,221) 14.9% (age-adjusted, 95% CL 12.5, 17.4) were antibody positive. T. gondii antibody prevalence was higher among non-Hispanic black persons than among non-Hispanic white persons (age-adjusted prevalence 19.2% vs. 12.1%, p=0.003) and increased with age. No statistically significant differences were found between T. gondii antibody prevalence in NHANES 1999–2000, and NHANES III. T. gondii antibody prevalence has remained stable over the past 10 years in the United States.
format Text
id pubmed-3035540
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-30355402011-02-15 Toxoplasma gondii Infection in the United States, 1999–2000 Jones, Jeffrey L. Kruszon-Moran, Deanna Wilson, Marianna Emerg Infect Dis Synopsis Infection with Toxoplasma gondii can lead to congenital and acquired disease, resulting in loss of vision and neurologic illness. We tested sera collected in the National Health and Examination Survey (NHANES) from 1999–2000 for T. gondii–specific immunoglobulin G antibodies and compared these results with results from sera obtained in the NHANES III survey (1988–1994). NHANES collects data on a nationally representative sample of the U.S. civilian population. Of 4,234 persons 12–49 years of age in NHANES 1999–2000, 15.8% (age-adjusted, 95% confidence limits [CL] 13.5, 18.1) were antibody positive; among women (n=2,221) 14.9% (age-adjusted, 95% CL 12.5, 17.4) were antibody positive. T. gondii antibody prevalence was higher among non-Hispanic black persons than among non-Hispanic white persons (age-adjusted prevalence 19.2% vs. 12.1%, p=0.003) and increased with age. No statistically significant differences were found between T. gondii antibody prevalence in NHANES 1999–2000, and NHANES III. T. gondii antibody prevalence has remained stable over the past 10 years in the United States. Centers for Disease Control and Prevention 2003-11 /pmc/articles/PMC3035540/ /pubmed/14718078 http://dx.doi.org/10.3201/eid0911.030098 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Jones, Jeffrey L.
Kruszon-Moran, Deanna
Wilson, Marianna
Toxoplasma gondii Infection in the United States, 1999–2000
title Toxoplasma gondii Infection in the United States, 1999–2000
title_full Toxoplasma gondii Infection in the United States, 1999–2000
title_fullStr Toxoplasma gondii Infection in the United States, 1999–2000
title_full_unstemmed Toxoplasma gondii Infection in the United States, 1999–2000
title_short Toxoplasma gondii Infection in the United States, 1999–2000
title_sort toxoplasma gondii infection in the united states, 1999–2000
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035540/
https://www.ncbi.nlm.nih.gov/pubmed/14718078
http://dx.doi.org/10.3201/eid0911.030098
work_keys_str_mv AT jonesjeffreyl toxoplasmagondiiinfectionintheunitedstates19992000
AT kruszonmorandeanna toxoplasmagondiiinfectionintheunitedstates19992000
AT wilsonmarianna toxoplasmagondiiinfectionintheunitedstates19992000